The purpose of this review is to illuminate the involvement of mTOR signaling in the pathogenesis of adenomyosis, endometriosis, endometritis, and typical endometrial hyperplasia and to address its potential as a therapeutic target for these conditions. Here, MTOR is linked to endometritis.